SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-017770
Filing Date
2024-02-28
Accepted
2024-02-28 09:00:38
Documents
16
Period of Report
2024-02-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0200582-8k_cerothera.htm   iXBRL 8-K 40304
2 PURCHASE AGREEMENT, DATED AS OF FEBRUARY 23, 2024, BY AND BETWEEN CERO THERAPEUT ea0200582ex10-1_cerother.htm EX-10.1 242558
  Complete submission text file 0001213900-24-017770.txt   555755

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cero-20240223.xsd EX-101.SCH 3798
4 XBRL DEFINITION FILE cero-20240223_def.xml EX-101.DEF 26673
5 XBRL LABEL FILE cero-20240223_lab.xml EX-101.LAB 36817
6 XBRL PRESENTATION FILE cero-20240223_pre.xml EX-101.PRE 25297
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0200582-8k_cerothera_htm.xml XML 5861
Mailing Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080 650-407-2376
CERO THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001870404 (see all company filings)

IRS No.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40877 | Film No.: 24690507
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)